• Home
  • Products & Services
    • VBS Pharmaceuticals
      • CAR Peptide Technology
      • CAR Peptide Applications
        • Co-administered Therapeutics
        • Pulmonary Hypertension
        • Sepsis
        • Gene Therapy
    • VBS Interventional
      • Interventional Technology
        • Endoarterial Biopsy Catheter
        • Endoarterial Biopsy Procedure
        • Endoarterial Biopsy Sequence
        • Endoarterial Biopsy Sample
        • Single Use Components
        • Endoarterial Biopsy Kit
      • Interventional Applications
        • Pulmonary Arterial Hypertension
        • Peripheral Vascular Disease
        • Lung Transplant Rejection
        • Vasculitis/Collagen Vascular Disease
        • Coronary Artery Disease
        • Critical Care Applications — Acute Lung Injury & Acute Respiratory Distress Syndrome
        • Lung Cancer
    • VBS Molecular Diagnostics
      • Molecular Diagnostics Technology
  • Product Pipeline
  • COVID-19
  • News
  • About VBS
    • VBS Team
    • VBS Board of Directors
  • VBS Scientific Articles
  • Investment
  • Contact

Vascular BioSciences to Make Six Presentations at the American Thoracic Society in San Francisco from May 15 – May 18

May 12, 2016
by admin
Comments are off
Vascular BioSciences to Make Six Presentations at the American Thoracic Society in San Francisco from May 15 – May 18 Vascular BioSciences to present the full scope of its research efforts at this year’s ATS International ConferenceGoleta, CA, May 12, 2016 – Vascular BioSciences annou
Read More

Vascular BioSciences Named the 2015 Winner of the Buzz of Bio “Pipelines of Promise” Competition

May 21, 2015
by admin
Comments are off
Vascular BioSciences Named the 2015 Winner of the Buzz of Bio “Pipelines of Promise” Competition Goleta, CA, May 21, 2015 – On April 30, 2015, the Biotech International Organization (BIO) announced Vascular BioSciences (VBS) as the winner of its Buzz of BIO competition in the “P
Read More

The American Journal of Pathology Highlights “CAR Selectively Enhances Drug Efficacy in PAH” as a Featured Article in the February 2014 Issue

Feb 05, 2014
by admin
Comments are off
The American Journal of Pathology Highlights “CAR Selectively Enhances Drug Efficacy in PAH” as a Featured Article in the February 2014 Issue Goleta, CA, February 5, 2014 – The American Journal of Pathology announced in a press release that a peer-reviewed scientific article about Vas
Read More

Vascular BioSciences Announces Online Publication of Scientific Article Describing First Orally Available Disease Homing Peptide That Can Selectively Enhance the Effects of Co-Administered Drugs

Jan 06, 2014
by admin
Comments are off
Vascular BioSciences Announces Online Publication of Scientific Article Describing First Orally Available Disease Homing Peptide That Can Selectively Enhance the Effects of Co-Administered Drugs Goleta, CA, January 6, 2014 – Vascular BioSciences announces the e-publication of “A
Read More

Vascular BioSciences Awarded $1.2 Million Contract from the NHLBI’s Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program to Develop CAR Peptide Therapeutic Adjuvant for PAH Targeted Therapy

Jan 02, 2014
by admin
Comments are off
Vascular BioSciences Awarded $1.2 Million Contract from the NHLBI’s Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program to Develop CAR Peptide Therapeutic Adjuvant for PAH Targeted Therapy Durham, NC – Vascular BioSciences (VBS) announced the award of a $1.2 mil
Read More

Vascular BioSciences announces publication of “Vascular Histomolecular Analysis By Sequential Endoarterial Biopsy in a Shunt Model of Pulmonary Hypertension” in the Current Issue of Pulmonary Circulation

Apr 10, 2013
by admin
Comments are off
Vascular BioSciences announces publication of “Vascular Histomolecular Analysis By Sequential Endoarterial Biopsy in a Shunt Model of Pulmonary Hypertension” in the Current Issue of Pulmonary Circulation Goleta, CA., April 10, 2013 – Vascular BioSciences announces the publication of “
Read More

Vascular BioSciences recently awarded a NIH SBIR/STTR Phase I Commercialization Assistance Award to develop the CAR peptide as a therapeutic adjuvant.

Oct 11, 2012
by admin
Comments are off
Vascular BioSciences recently awarded a NIH SBIR/STTR Phase I Commercialization Assistance Award to develop the CAR peptide as a therapeutic adjuvant. Goleta, CA., October 11, 2012 – Vascular BioSciences recently awarded a NIH SBIR/STTR Phase I Commercialization Assistance Award to de
Read More

Vascular BioSciences announces CEO David Mann will present “CAR Peptide, a Disease Selective Therapeutic Adjuvant For Targeted Drug Therapy” during the 7th Annual Therapeutic Peptide Symposium

Oct 10, 2012
by admin
Comments are off
Vascular BioSciences announces CEO David Mann will present “CAR Peptide, a Disease Selective Therapeutic Adjuvant For Targeted Drug Therapy” during the 7th Annual Therapeutic Peptide Symposium San Diego, CA., October 10, 2012 – Vascular BioSciences announces CEO David Mann will presen
Read More

Vascular BioSciences announced today that Dr. Kalju Kahn, PhD, has been named head of Medicinal Chemistry

Jul 03, 2012
by admin
Comments are off
Vascular BioSciences announced today that Dr. Kalju Kahn, PhD, has been named head of Medicinal Chemistry Goleta, Calif., July 3, 2012 – Vascular BioSciences announced today that Dr. Kalju Kahn, PhD, has been named head of Medicinal Chemistry. Dr. Kahn, an expert in computational chem
Read More

Vascular Biosciences announces publication of “Hemodynamic and Histologic Characterization of a Swine (Sus scrofa domestica) Model of Chronic Pulmonary Arterial Hypertension”

Jun 27, 2011
by admin
Comments are off
Vascular Biosciences announces publication of “Hemodynamic and Histologic Characterization of a Swine (Sus scrofa domestica) Model of Chronic Pulmonary Arterial Hypertension” Durnham, North Carolina, June 27, 2011 – Vascular BioSciences announces the publication of a scientific articl
Read More
1234
  • Home
  • Products & Services
  • Product Pipeline
  • News
  • About VBS
  • VBS Scientific Articles
  • Investment
  • Contact Info
  • Privacy Policy